|
|
 |
|
Viewing report
|
|
|
|
Delivering Drugs by Inhalation
Greystone Associates, Aug 2009, Pages: 160
Advances in drug formulation and inhalation device design are creating new opportunities for inhaled drug delivery as an alternative to oral and parenteral delivery methods. Much of the interest in pulmonary delivery of systemic drug therapies is focused on chronic diseases and refractory conditions – aliments that require frequent drug administration for a protracted period of time.
The role of device design and development in defining and driving emerging opportunities in this sector cannot be overstated. Nebulizers, metered dose inhalers (MDIs), and dry powder inhalers (DPIs) have each found a niche in the quest for optimal treatment and convenient use. While nebulizers have evolved relatively independently of the drug formulations they deliver, the current generation of MDIs and DPIs have been developed or tailored for the specific pharmaceutical being delivered, resulting in improved performance.
Several of the emerging drug products covered in this report will have a significant impact in the therapeutic markets they target, improving patient compliance and effectively changing the way important illnesses and conditions are treated.
Feature Summary
- Analyzes and evaluates inhaled drugs currently in development and assesses the market potential for existing and probable future products
- Examines inhalation device technology for commercial and development-stage devices, and evaluates product technology issues and evolving market factors
- Provides detailed assessments of targeted disease segments, forecast growth and market potential, and therapeutic options
- Forecasts the impact of new and emerging inhaled drug therapeutics on healthcare markets and prescribing decisions to 2012
- Profiles Inhaled drug product market participants, their technology, product development activity, and business strategies
- Evaluates the impact of economic, technology, and regulatory factors on inhaled drug companies and their alliance partners
Methodology
- Research methodology is based on primary research in the form of in-depth interviews with key market participants, technology developers, distributors, industry experts, and market influencers, a list that includes regulatory officials, industry trade groups, and materials standards organizations.
- Primary data is evaluated and normalized against secondary sources including trade journal articles, technical literature, industry publications, company data sheets and published information, and statistical data from government agencies and trade associations.
- Forecasts and projections of market demand and future market activity are derived using standard modeling and statistical techniques.
Customers who bought this item also bought
Delivering Drugs by Inhalation - Emerging Therapeutic Opportunities
Inhaled CNS Therapeutics - Markets & Opportunities
Pulmonary Drug Delivery Technologies - Global Strategic Business Report
Pulmonary Drug Delivery Technologies - A Global Market Perspective
Inhalers Clinical Trial Analysis
The Top 40 Developers Of Inhaled Pharmaceuticals Worldwide
Drug Delivery for Self-Administration Report - Technologies, Combination
Metered Dose Inhalers Clinical Trial Analysis
Key Trends in the Asthma and Copd Market - Uncertain times for novel inhalation devices
The 2009-2014 Outlook for Metered Dose Inhalers (MDI) in Europe
The 2009-2014 Outlook for Metered Dose Inhalers (MDI) in The Middle East
The 2009-2014 Outlook for Metered Dose Inhalers (MDI) in Asia
|
|
|
|
